ACCESSION: MSBNK-SMB_Measured-HSA033P0182006
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.04.01, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 11
COMMENT: RAW_SPEC {'C18neg_4675': {'bp': 2461.0, 'sum': 8487.0}, 'D147neg_4805': {'bp': 1924.0, 'sum': 4386.0}, 'D73neg_4726': {'bp': 1559.0, 'sum': 4418.0}, 'D122neg_4937': {'bp': 1383.0, 'sum': 4633.0}, 'C3neg_4671': {'bp': 1328.0, 'sum': 3752.0}, 'D142neg_4685': {'bp': 1327.0, 'sum': 4001.0}, 'D126neg_4754': {'bp': 937.0, 'sum': 2780.0}, 'D65neg_4689': {'bp': 855.0, 'sum': 3426.0}, 'D146neg_4542': {'bp': 828.0, 'sum': 2443.0}, 'C16neg_4661': {'bp': 614.0, 'sum': 1774.0}, 'D170neg_4519': {'bp': 447.0, 'sum': 1203.0}}
COMMENT: RETENTION_TIME_STDEV 0.040
COMMENT: PRECURSOR_M/Z_RAW 182.056211
COMMENT: PRECURSOR_M/Z_STDEV 0.000775
COMMENT: PRECURSOR_IN_MS1 mz 182.056259; int 227.197; delta(ppm) -0.842041
COMMENT: PROPOSED_CHARGE_STATE -1; mz 183.059869; int 21.390; cor 0.918
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M-H2O-H; mz 164.045398; int 3.026; cor 0.709
COMMENT: PROPOSED_ION_FORM M-H; M+Na-2H; mz 204.037243; int 6.880; cor 0.682
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 13.351; C5H14NO4P; [M-H]1; delta(ppm) -13.350551
COMMENT: PROPOSED_MF SevenGoldenRules 4.326; C7H9N3O3; [M-H]1; delta(ppm) -4.326365
COMMENT: PROPOSED_MF MS-FINDER 4.177; C7H9N3O3; [M-H]-; delta(ppm) -4.348874
COMMENT: PROPOSED_MF MS-FINDER 2.351; C5H14NO4P; [M-H]-; delta(ppm) -13.421546
COMMENT: PROPOSED_MF SIRIUS5_Sirius 22.758; C7H9N3O3; [M-H]-; delta(ppm) -4.348874
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H9N3O3; [M-H]-; delta(ppm) -4.348874
COMMENT: PROPOSED_MF SIRIUS6_Sirius 32.079; C7H9N3O3; [M-H]-; delta(ppm) -4.348874
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.132; C4H11N2O6; [M-H]-; delta(ppm) 10.372360
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.098; C5H8F3N3O; [M-H]-; delta(ppm) 9.082615
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.569; C4H10FN3O4; [M-H]-; delta(ppm) -10.625156
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.597; C3H12N4O3P; [M-H]-; delta(ppm) -6.046699
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.059; C5H7N6O2; [M-H]-; delta(ppm) 3.026107
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.846; C5H15N2OS2; [M-H]-; delta(ppm) 5.598939
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.956; C5H11F2N3S; [M-H]-; delta(ppm) -3.158030
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.777; C3H5N9O; [M-H]-; delta(ppm) 10.401196
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.446; CH10N7O2P; [M-H]-; delta(ppm) 1.328256
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H9N3O3; [M-H]-; delta(ppm) -4.348874
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.382; VTCIMOUIYHJWAL-UHFFFAOYSA-N; [M-H]-; CN(C)C(=O)C1=CC(=O)NC(=O)N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.218; HRRHGLKNOJHIGY-UHFFFAOYSA-N; [M-H]-; CCOC(=O)C1=CN=C(N)N=C1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.194; RJXQOURJIQZYIP-UHFFFAOYSA-N; [M-H]-; O=C(O)CC=1C(=O)NC(=NC1C)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; JNFVSJNYOFOUDD-UHFFFAOYSA-N; [M-H]-; FC=1C=C2C(OCOC2)=C(C1)CN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; WXCQAWGXWVRCGP-UHFFFAOYSA-N; [M-H]-; C[N+](C)(C)CCOS([O-])(=O)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.809; RJXQOURJIQZYIP-UHFFFAOYSA-N; [M-H]-; 2-(2-amino-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.383; HRRHGLKNOJHIGY-UHFFFAOYSA-N; [M-H]-; ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.907; VTCIMOUIYHJWAL-UHFFFAOYSA-N; [M-H]-; UNPD146576
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.650; VQMWRUKXHJGSIE-UHFFFAOYSA-N; [M-H]-; 4-amino-2-hydroxylamino-6-nitrotoluene
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; RJXQOURJIQZYIP-UHFFFAOYSA-N; [M-H]-; 2-(2-amino-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.854; VQMWRUKXHJGSIE-UHFFFAOYSA-N; [M-H]-; 4-amino-2-hydroxylamino-6-nitrotoluene
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.790; VTCIMOUIYHJWAL-UHFFFAOYSA-N; [M-H]-; UNPD146576
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.671; HRRHGLKNOJHIGY-UHFFFAOYSA-N; [M-H]-; ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.285; NLXRQOREXATYEE-UHFFFAOYSA-N; [M-H]-; 2-methyl-5-nitro-1-(oxiran-2-ylmethyl)imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.267; AEKVVFWCBKEYSC-UHFFFAOYSA-N; [M-H]-; 2-ethyl-6-nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.251; STGZMDMCSWZWHU-UHFFFAOYSA-N; [M-H]-; 2-[(5-nitropyridin-2-yl)amino]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.245; HRRHGLKNOJHIGY-UHFFFAOYSA-N; [M-H]-; ethyl 2-amino-6-oxo-1H-pyrimidine-5-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.996; PCZJMSVFHJMNSC-UHFFFAOYSA-N; [M-H]-; (3-methoxy-4-nitrophenyl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.873; LGXGZORRPBTMAO-UHFFFAOYSA-N; [M-H]-; 4-amino-1,3-dimethyl-2,6-dioxopyrimidine-5-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.775; PMCIWYPDCBJOCD-UHFFFAOYSA-N; [M-H]-; 2-amino-3-(6-oxo-1H-pyrimidin-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.725; RJXQOURJIQZYIP-UHFFFAOYSA-N; [M-H]-; 2-(2-amino-4-methyl-6-oxo-1H-pyrimidin-5-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.648; GVHTUTAPGOWNIV-UHFFFAOYSA-N; [M-H]-; methyl 5-carbamoyl-1-methylpyrazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.621; BYBYUDDRIJYSPK-UHFFFAOYSA-N; [M-H]-; (2-methoxy-4-nitrophenyl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; BWEQHSCBXQZUGJ-UHFFFAOYSA-N; [M-H]-; N-(furan-2-ylmethyl)-2-hydrazinyl-2-oxoacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.417; VQMWRUKXHJGSIE-UHFFFAOYSA-N; [M-H]-; N-(5-amino-2-methyl-3-nitrophenyl)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.406; NGYYYNPZWSICGP-UHFFFAOYSA-N; [M-H]-; 3-oxo-5,6,7,8-tetrahydro-2H-[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.402; FKNLOWWPOKPDIA-UHFFFAOYSA-N; [M-H]-; 3-oxo-5,6,7,8-tetrahydro-2H-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.348; RSFNGZVULJTWHW-UHFFFAOYSA-N; [M-H]-; 6-methoxy-N-methyl-3-nitropyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.343; JJTQVDBZMRFIGY-UHFFFAOYSA-N; [M-H]-; 3-oxo-5,6,7,8-tetrahydro-2H-[1,2,4]triazolo[4,3-a]pyridine-7-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.319; UPHBQNQMBKVLRU-UHFFFAOYSA-N; [M-H]-; 6,7-dihydro-4H-pyrano[3,4-d][1,2]oxazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.309; GCSMZTUEDJLQSP-UHNVWZDZSA-N; [M-H]-; (2S,5R)-5-(1H-1,2,4-triazol-5-yl)oxolane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.296; MPNPONGMMJRKPD-SCSAIBSYSA-N; [M-H]-; (8R)-8-hydroxy-2-methyl-7,8-dihydro-6H-pyrrolo[2,1-c][1,2,4]triazine-3,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.290; WAZQYQQNKFUNFO-UHFFFAOYSA-N; [M-H]-; 2-amino-3-(6-oxo-1H-pyrimidin-5-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.290; LMKVAFXOGILNGT-UHFFFAOYSA-N; [M-H]-; 2-amino-3-(6-oxo-1H-pyrimidin-4-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.202; SSPWGFZESFIBDD-UHFFFAOYSA-N; [M-H]-; 2-(6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.166; IXZWFWCANQSSMJ-UHFFFAOYSA-N; [M-H]-; 6-amino-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.123; BQKKDFSYRPCJOS-UHFFFAOYSA-N; [M-H]-; methyl 2-(2-amino-6-oxo-1H-pyrimidin-4-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.110; VAEIHNPPOAVFAR-UHFFFAOYSA-N; [M-H]-; ethyl 5-formamido-1H-pyrazole-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; VMZCIAQOMWFRDC-UHFFFAOYSA-N; [M-H]-; 1,3-dimethyl-2,4-dioxopyrimidine-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.021; LYHIKNKEQITTAB-UHFFFAOYSA-N; [M-H]-; 1-(oxolan-3-yl)triazole-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.969; MLTOOLRXORLYOJ-UHFFFAOYSA-N; [M-H]-; 2-amino-4-(methoxymethyl)pyrimidine-5-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.940; YIKZHRIABJQJCR-UHFFFAOYSA-N; [M-H]-; 2,5-dioxo-1,3,6,7-tetrahydropyrrolo[1,2-a]imidazole-7a-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.771; WVBSKULOIAYZFS-UHFFFAOYSA-N; [M-H]-; methyl 6-amino-5-methoxypyrimidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.652; WVRKFYAELTYHPX-UHFFFAOYSA-N; [M-H]-; 2-(3-hydroxy-4-methanimidoyl-5-oxo-2H-pyrrol-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -92.522; WFQVSLVQIFFQQN; [M-H]-; NCIStruc1_000292
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -156.390; WYZGJTDHNAZBRC; [M-H]-; 3-(2-Carboxyethyl)cytosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.586; MOAJIKUCBRTVEM; [M-H]-; Boc-DL-ala-imidazolide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.666; HRRHGLKNOJHIGY; [M-H]-; ethyl 2-amino-6-oxo-1H-pyrimidine-5-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.430; NLXRQOREXATYEE; [M-H]-; 1-(2,3-Epoxypropyl)-2-methyl-5-nitroimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -281.340; BQKKDFSYRPCJOS; [M-H]-; methyl 2-(2-amino-4-oxo-1H-pyrimidin-6-yl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.588; RJXQOURJIQZYIP; [M-H]-; 2-(2-amino-6-methyl-4-oxo-1H-pyrimidin-5-yl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -305.107; VTCIMOUIYHJWAL; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.150; RSFNGZVULJTWHW; [M-H]-; 2-Methylamino-3-nitro-6-methoxypyridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.631; LGXGZORRPBTMAO; [M-H]-; 4-amino-1,3-dimethyl-2,6-dioxopyrimidine-5-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -330.361; STGZMDMCSWZWHU; [M-H]-; Oprea1_450088
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -346.434; AEKVVFWCBKEYSC; [M-H]-; 2,3-Dihydro-2-ethyl-6-nitroimidazo(2,1-b)oxazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -372.294; VQMWRUKXHJGSIE; [M-H]-; 4-amino-2-hydroxyamino-6-nitrotoluene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -380.859; NGYYYNPZWSICGP; [M-H]-; 3-oxo-2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -393.892; FKNLOWWPOKPDIA; [M-H]-; 3-oxo-2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -533.973; WVRKFYAELTYHPX; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -587.019; YIKZHRIABJQJCR; [M-H]-; 2,5-Dioxohexahydro-1H-pyrrolo(1,2-a)imidazole-7a-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.554; WFQVSLVQIFFQQN; [M-H]-; NCIStruc1_000292
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -63.781; WFQVSLVQIFFQQN; [M-H]-; N-Formylhistidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -168.635; MOAJIKUCBRTVEM; [M-H]-; Tertiary-butyloxycarbonyl-alanine imidazolide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -174.208; WYZGJTDHNAZBRC; [M-H]-; 3-(2-Carboxyethyl)cytosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -224.059; NLXRQOREXATYEE; [M-H]-; 1-(2,3-Epoxypropyl)-2-methyl-5-nitroimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -236.893; IGDOXQQHTMMUDA; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -243.723; STGZMDMCSWZWHU; [M-H]-; 2-((5-Nitropyridin-2-yl)amino)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -258.289; LGXGZORRPBTMAO; [M-H]-; 6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -258.969; GVHTUTAPGOWNIV; [M-H]-; methyl 5-carbamoyl-1-methyl-1H-pyrazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -273.025; NGYYYNPZWSICGP; [M-H]-; 3-oxo-2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -274.812; RJXQOURJIQZYIP; [M-H]-; 2-(2-amino-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.827; WFQVSLVQIFFQQN; [M-H]-; N-Formylhistidine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H8N3O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 µm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 5.102
MS$FOCUSED_ION: PRECURSOR_M/Z 182.056323
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000x-9100000000-57f2582bf42331908dcf
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  41.9980642 999.0000 41.998060 11.3339 0.00 1.0000 10 f{C1N1O1}/-11.26ppm,p-C6H8N2O2
  69.0089749 226.6859 69.008936 10.5928 65.22 0.6319 10 f{C2H1N2O1}/-6.69ppm,p-C5H7N1O2
  80.0367583 126.7265 80.036708 7.8589 54.36 0.8152 10 f{C4H4N2}/-15.47ppm,p-C3H4N1O3
  81.0450921 491.1969 81.045042 6.9344 145.33 0.8788 11 f{C4H5N2}/-9.00ppm,p-C3H3N1O3
  93.0447783 140.1628 93.044729 8.0069 51.72 0.8285 10 f{C5H5N2}/-11.21ppm,p-C2H3N1O3
  110.0711587 325.8335 110.071114 7.2135 113.56 0.8667 11 f{C5H8N3}/-11.01ppm,p-C2O3
  111.0305288 63.0603 111.030485 8.9435 33.02 0.3298 8 f{C5H5N1O2}/-18.45ppm,p-C2H3N2O1
PK$NUM_PEAK: 7
PK$PEAK: m/z int. rel.int.
  41.998064 999.00 999
  69.008975 226.69 226
  80.036758 126.73 126
  81.045092 491.20 491
  93.044778 140.16 140
  110.071159 325.83 325
  111.030529 63.06 63
//
